Piecing together an attractive resume for employers can be a difficult feat, causing many to seek out the best resume writing ...

(R to L) EY's Ricardo Vilanova, Lila Bioscience's Molly Gibson, Merck's Iya Khalil, Insitro's Mary Rozenman, and Gallop Oncology's Luba Greenwood at BIO 2025. When Google shook the foundations of the ...

Trial shows GRI-0621 improved lung function with signs of fibrosis resolution GRI Bio has announced positive topline results from its phase 2a clinical trial evaluating GRI-0621 in idiopathic ...

After yet another year of high-profile news stories and internet trends, Merriam-Webster has chosen one word to sum up 2025: “slop.” The dictionary publisher defined it as “digital content of low ...

The BioWorld Biopharmaceutical Index extended its autumn rally after a more modest September, finishing November up 23.41% for the year. The gain lagged the Nasdaq Biotechnology Index, which surged 34 ...

To describe themselves on dating apps and make a good first impression, some men use "sell" words. These qualifying adjectives are chosen with the utmost care. There's one that often comes up in ...

Northwest Biotherapeutics, Inc., a biotechnology company, focuses on developing personalized immune therapies for cancer. The company develops DCVax, a platform technology that uses activated ...

The BAC DNA MiniPrep Kit is designed for the rapid preparation of BACs (bacterial artificial chromosomes) and other large DNA constructs from small batch cultures of Escherichia coli. Purification of ...

The TC20 automated cell counter counts mammalian cells in one simple step using its innovative auto-focus technology and sophisticated cell counting algorithm to produce accurate cell counts in less ...

Learn how to calculate the face value of a life insurance policy and discover factors that might influence changes in this ...

Christopher Mims is a columnist who writes about technology for The Wall Street Journal's tech bureau in San Francisco. The subjects of his columns vary widely from one week to the next. He has ...